SCHEMBL6206320

SCHEMBL6206320

Cc1cc(OCCBr)ccc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.50
PPARG P37231 3/20 0.48
PPARD Q03181 3/20 0.48
PPARA Q07869 1/20 0.47
FFAR1 O14842 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
ALOX5 P09917 1/20 0.45
MAOB P27338 4/20 0.43
MRGPRX4 Q96LA9 2/20 0.43
HTR1A P08908 1/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
PKM P14618 1/20 0.42
NPC1 O15118 1/20 0.42
MAOA P21397 1/20 0.42
CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1439758 0.88 PPARD (0.58) FFAR4PPARGPPARDFFAR1TDP1
SCHEMBL3229614 0.84 RAB9A (0.51) MAPTALOX5MAOBHTR1AADRA1D
SCHEMBL7371207 0.82 FFAR1 (0.46) PPARGPPARDFFAR1ALOX5MAOB
SCHEMBL7401147 0.82 PPARG (0.46) PPARGPPARDPPARAMAPTNPC1
SCHEMBL8940493 0.81 PPARG (0.52) FFAR4PPARGPPARDPPARAFFAR1
SCHEMBL7402902 0.80 ALOX5 (0.71) PPARGTDP1L3MBTL1MAPTMAPK1
SCHEMBL14925312 0.79 PPARD (0.51) FFAR4PPARGPPARDPPARAFFAR1
SCHEMBL1172598 0.79 LMNA (0.62) L3MBTL1MAPTALOX5MAOBMAOA
Hydrochloric Acid SCHEMBL27830190 0.79 MAOB (0.57) FFAR4PPARGPPARDTDP1L3MBTL1
SCHEMBL12459903 0.79 PPARG (0.53) FFAR4PPARGPPARDFFAR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869792-B1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 2005-03-09 EP disclosed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023202-A1 SUBTYPE-SELECTIVE NMDA RECEPTOR LIGANDS AND THE USE THEREOF STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITYA ND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-07-03 WO disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed